Basic Information
THYROCORD 25 TABLET 25 MCG
TABLET
Regulatory Information
SIN16701P
February 21, 2023
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XH03AA01
Company Information
Active Ingredients
Strength: 0.025 mg
Detailed Information
Contraindications
**CONTRAINDICATIONS** Thyrocord must not be used in patients with: - hypersensitivity to any of the excipients of the product (see 'Composition' – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_) - untreated adrenal insufficiency - untreated pituitary insufficiency - hyperthyroidism or untreated thyrotoxicosis, including untreated subclinical (suppressed serum TSH level with normal T3 and T4 levels) hyperthyroidism. Treatment with levothyroxine must not be initiated in patients with acute myocardial infarction, acute myocarditis, or acute pancarditis. Combination therapy of Thyrocord and an antithyroid agent for hyperthyroidism is not indicated during pregnancy.
Indication Information
**INDICATIONS** Hypothyroidism.